FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/05/2025
Back to search
Official data from USPTO
NOVACUTAN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
NOVACUTAN
ST13
US500000079379230Class
3, 5, 10, 42, 44
Filing
79379230
Registration
7772575
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
04/03/2026
Classification
Registered
Trademark type
Word
Nice classes
3, 5, 10, 42, 44
Filing date
07/05/2023
Registration date
04/29/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/29/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
34
Owner location
FR
Examiner
PAPALE, LISA ANNE
Law office
N30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
L. F. (pessoa física)
Representatives
Amanda M. Prose WESTMAN, CHAMPLIN & KOEHLER, P.A.
Technical classification
Nice Classes
Class 3Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
cosmetic productsnamely beauty creamsgelslotionsmaskscosmetic powdersbody emulsionsbeauty serumsshampooshair conditionersbath foamsbody sprays; cosmetic products based on hyaluronic acidnamely beauty creamsgelslotionsmaskscosmetic powdersbody emulsionsbeauty serumsshampooshair conditionersbath foamsbody sprays; cosmetic products based on hyaluronic acid for hypodermic injections
Class 5
pharmaceutical preparations based on Botulinum toxin type A-hemagglutinin complex for treatment of blepharospasm and chronic migraine and for use in cosmetic medicine; pharmaceutical preparations based on hyaluronic acidnamely for hypodermic injectionsfor treatment of arthrosis and for use in ophtalmic surgery; biological preparations for medical use for the treatment of blepharospasm and chronic migraine and for use in cosmetic medicine; biological preparations for medical use for the treatment of arthrosis and for use in ophtalmic surgery; vitamin preparations; mineral supplements; albuminous multivitamin preparations for medical use
Class 10
medical productsincluding based on hyaluronic acidnamely dermal fillersgel filler; implantsincluding surgical and medical implantsincluding those made from materials that are artificialintradermalintradermal based on hyaluronic acid or hyaluronic-acid-based materialsnamely implants comprising naturalnon-living materials; cannulae; surgical and medical apparatus and instrumentsnamely injection needles with round end points with lateral eyes; implantable devicesnamely implantable drug delivery ports for the subcutaneous release of medicated substances; syringes for medical use; syringes for injections; hypodermic syringes
Class 42
Research and development of new productsfor others; biological research; scientific research services in the field of cosmetology
Class 44
Medical services; cosmetology servicesincluding beautician services and artist make-up services; hygienic care services for individuals; hairdressing services; manicure services; massage; advisory services in the field of cosmetic body and beauty care; advisory services concerning medical services; consultation with respect to pharmacy
Publications
History of USPTO decisions and trademark events.
27 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/14/2025
FIMP
FINAL DISPOSITION PROCESSED
11/14/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/29/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/29/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
04/29/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/11/2025
PUBO
PUBLISHED FOR OPPOSITION
03/11/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/08/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/05/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/20/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/20/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/12/2025
DOCK
ASSIGNED TO EXAMINER
02/07/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/02/2024
RFNT
REFUSAL PROCESSED BY IB
04/30/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/05/2024
RFRR
REFUSAL PROCESSED BY MPU
04/05/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/19/2024
CNRT
NON-FINAL ACTION WRITTEN
03/18/2024
DOCK
ASSIGNED TO EXAMINER
03/18/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/24/2023
MAFR
APPLICATION FILING RECEIPT MAILED
09/26/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/22/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/21/2023
Continuous trademark protection
Get notified about every new filing that threatens NOVACUTAN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.